A study where GC and matched normal tissues were used to evaluate the expression of MAP4K4 showed that in 72% of GC patients, MAP4K4 is overexpressed compared to its levels in matched normal tissues [76]. This evidence concerns the gene MAP4K4 and gastric cancer.